Social implement Laboratories

Braizon Therapeutics Inc.


Braizon’s DDS technology was granted a patent in Japan in February 2017, along with publication of an article in Nature Communications in October 2017. On the basis of this base patent, the company is taking active steps to apply for substance patents including micelles for use in drug delivery. Braizon’s business places priority on licensing-out the base technology,